• Search chemicals, activators, Inhibitors, APIs, intermediates and raw materials.

509102-00-5 (MIM1)

1

Identification

MIM1 MIM1
Name MIM1
Formula C17H21N3O3S
MW 347.43
CAS No. 509102-00-5
EINECS
Smiles OC1=C(O)C(/C=N/N2/C(SC=C2C)=N/C3CCCCC3)=CC=C1O
Synonyms MIM 1;MIM-1;Inhibitor of Mcl-1; 4-((E)-(((Z)-2-(cyclohexylimino)-4-methylthiazol-3(2H)-yl)imino)methyl)benzene-1,2,3-triol
InChI InChI=1S/C17H21N3O3S/c1-11-10-24-17(19-13-5-3-2-4-6-13)20(11)18-9-12-7-8-14(21)16(23)15(12)22/h7-10,13,21-23H,2-6H2,1H3/b18-9+,19-17-
2

Introduction

MIM1 is a selective small molecule inhibitor of Mcl-1(IC50= 4.8 uM) that overcomes Mcl-1-dependent leukemia cell survival. IC50 value: 4.8 uM Target: Mcl-1 MIM1 effectively competed with FITC-MCL-1 SAHBA and FITC-BID BH3 for MCL-1ΔNΔC binding with respective IC50s of 4.7 and 4.8 μM, the compound showed no capacity to displace FITC-BID BH3 from BCL-XLΔC (IC50>50 μM), mirroring the selectivity of MCL-1 SAHBD. Although MCL-1 SAHBD was a 30 to 60-fold more potent competitor for MCL-1ΔNΔC binding than MIM1, the MCL-1 selective small molecule is one-seventh the size of the stapled peptide and exhibits an IC50 for its target (4.8 μM) that is only 7.5-fold less than that of chemically-optimized ABT-737 for BCL-XLΔC (0.63 μM) upon competition with FITC-BID BH3.

Background Information

Selective MCL-1 ligand killing MCL-1-dependent leukemia cells ......by AOBIOUS INC
MIM1 is a small molecule inhibitor of Mcl-1 (IC50= 4.8 uM) by selectively targets the BH3-binding pocket. ......by BOC Sciences
MIM-1 is an inhibitor of myeloid cell factor 1 (Mcl-1). ......by MedChemexpress Co., Ltd.
3

Protocol(Only for Reference)

Cell Experiment

Animal Experiment

4

Physical and Chemical Properties

Appearance:White to off-white Solid EBNumber:EB000010106

Storage condition

Solubility

DMSO by MedChemexpress Co., Ltd.
5

Mechanism and Indication

Signaling Pathways Apoptosis
Target Bcl-2 Family
Research Area Cancer
Indications
6

Clinical Information

Product Name Sponsor & Collaborators Indications Start Date End Date Phase
MIM1 - No Development Reported
7

Safety Data of MIM1

8

Spectral Information

9

Suppliers List

Company Price and Availability Country/Region
AOBIOUS INC 1mg/USD15() USA
BOC Sciences
CHEMSCENE, LLC 5mg/USD420();10mg/USD600() USA
MedChemexpress Co., Ltd. 5mg/USD420();10mg/USD600() USA
Shanghai Haoyuan Chemexpress Co., Ltd. 5mg/USD420();10mg/USD600() China
VDM BIOCHEMICALS,Inc. USA
10

Related Products

Other Forms of 509102-00-5

Name CAS No Formula MW

Recommended Compounds in Bcl-2 Family

Name CAS No Formula MW
713492-66-1
Gossypol (acetic acid) 12542-36-8 C32H34O10 578.6064
Marinopyrrole A 1227962-62-0 C22H12Cl4N2O4 510.15
WEHI-539 1431866-33-9 C31H29N5O3S2 583.72
Gambogic Acid 2752-65-0 C38H44O8 628.75
ABT-199 1257044-40-8 C45H50ClN7O7S 868.44
(±)-Apogossypol 475-56-9 C28H30O6 462.5342
Gossypol 303-45-7 C30H30O8 518.55
AT-101 90141-22-3 C30H30O8 518.55
BAM7 331244-89-4 C21H19N5O2S 405.47
SZ4TA2 406231-90-1 C28H32N4O5S2 568.71
TW-37 877877-35-5 C33H35NO6S 573.7
HA14-1 65673-63-4 C17H17BrN2O5 409.23
Obatoclax 803712-79-0 C21H23N3O4S 413.49
ABT-737 852808-04-9 C42H45ClN6O5S2 813.43
Navitoclax 923564-51-6 C47H55ClF3N5O6S3 974.61
Bax inhibitor peptide V5 579492-81-2 C27H50N6O6S 586.79
A-1331852 1430844-80-6 C38H38N6O3S 658.81
A-1155463 1235034-55-5 C35H32FN5O4S2 669.79
Bz 423 216691-95-1 C27H21ClN2O2 440.92

Recommended Compounds in Same Indication

Name CAS No Formula MW
11

Route of Synthesis

12

References

13

More Information

MIM1

Tags: buy 509102-00-5 IC50 | 509102-00-5 price | 509102-00-5 cost | 509102-00-5 solubility | 509102-00-5 purchase | 509102-00-5 manufacturer | 509102-00-5 research buy | 509102-00-5 order | 509102-00-5 MSDS | 509102-00-5 chemical structure | 509102-00-5 Storage condition | 509102-00-5 molecular weight | 509102-00-5 mw | 509102-00-5 datasheet | 509102-00-5 supplier | 509102-00-5 cell line | 509102-00-5 NMR | 509102-00-5 MS | 509102-00-5 IR | 509102-00-5 solubility | 509102-00-5 Safe information | 509102-00-5 Qc and Spectral Information | 509102-00-5 Clinical Information | 509102-00-5 Clinical Trial | 509102-00-5 Route of Synthesis | 509102-00-5 storage condition | 509102-00-5 diseases and conditions | 509102-00-5 flash point | 509102-00-5 boiling point | 509102-00-5 melting point | 509102-00-5 storage condition | 509102-00-5 brand